CD3 + CD19 (Blinatumomab biosimilar) Antibody from ICHORBIO

Search, find, compare suppliers for anti-CD3 + CD19 (Blinatumomab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD3 + CD19 (Blinatumomab biosimilar)
Clonemonoclonal
Host Speciesn/a
Reactive Specieshuman
Isotypen/a
FormatProtein A/G purified, low endotoxin
Size5mg
Concentration5mg/ml
ApplicationsFunctional Assays. RUO
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSpecificity: detects human CD3/CD19. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Blinatumomab. Blinatumomab is a bispecific T-cell engager (BiTE). It enables a patient's T cells to recognize malignant B cells. A molecule of blinatumomab combines two binding sites: a CD3 site for T cells and a CD19 site for the target B cells.
Immunogenn/a
Other Namesn/a
Gene, Accession #n/a
Catalog #ICH5025-5mg
Price$4000
Order / More InfoCD3 + CD19 (Blinatumomab biosimilar) Antibody from ICHORBIO
Product Specific Referencesn/a
ICHORBIO
ICHORBIO
ICHORBIO
Boston House, Grove Business Park
Downsview Road
Wantage OX12 9FF ENGLAND

orders@ichor.bio

https://ichor.bio

U.S. OFFICE
987 Old Eagle School Rd, Ste 709
Wayne, PA 19087
us@ichor.bio


Profile of ICHORBIO

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.